These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34071799)

  • 21. Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis.
    Sharma S; Baweja S; Maras JS; Shasthry SM; Moreau R; Sarin SK
    JHEP Rep; 2021 Jun; 3(3):100283. PubMed ID: 34095796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.
    Kim HY; Kim CW; Kim TY; Song DS; Sinn DH; Yoon EL; Jung YK; Suk KT; Lee SS; Lee CH; Kim TH; Kim JH; Yim HJ; Kim SE; Baik SK; Lee BS; Jang JY; Kim YS; Kim SG; Yang JM; Sohn JH; Lee HJ; Park SH; Choi EH; Kim DJ;
    World J Gastroenterol; 2016 Nov; 22(41):9205-9213. PubMed ID: 27895407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.
    Sandahl TD; Jepsen P; Ott P; Vilstrup H
    Scand J Gastroenterol; 2011 Sep; 46(9):1127-32. PubMed ID: 21591871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.
    Forrest EH; Morris AJ; Stewart S; Phillips M; Oo YH; Fisher NC; Haydon G; O'Grady J; Day CP
    Gut; 2007 Dec; 56(12):1743-6. PubMed ID: 17627961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).
    Duseja A; Choudhary NS; Gupta S; Dhiman RK; Chawla Y
    J Dig Dis; 2013 Sep; 14(9):484-90. PubMed ID: 23692973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
    Arab JP; Díaz LA; Baeza N; Idalsoaga F; Fuentes-López E; Arnold J; Ramírez CA; Morales-Arraez D; Ventura-Cots M; Alvarado-Tapias E; Zhang W; Clark V; Simonetto D; Ahn JC; Buryska S; Mehta TI; Stefanescu H; Horhat A; Bumbu A; Dunn W; Attar B; Agrawal R; Haque ZS; Majeed M; Cabezas J; García-Carrera I; Parker R; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de la Tijera MF; Kulkarni AV; Rao PN; Guerra Salazar P; Skladaný L; Bystrianska N; Prado V; Clemente-Sanchez A; Rincón D; Haider T; Chacko KR; Cairo F; de Sousa Coelho M; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Narvaez A; Bessone F; Marcelo JS; Piombino D; Dirchwolf M; Arancibia JP; Altamirano J; Kim W; Araujo RC; Duarte-Rojo A; Vargas V; Rautou PE; Issoufaly T; Zamarripa F; Torre A; Lucey MR; Mathurin P; Louvet A; García-Tsao G; González JA; Verna E; Brown RS; Roblero JP; Abraldes JG; Arrese M; Shah VH; Kamath PS; Singal AK; Bataller R
    J Hepatol; 2021 Nov; 75(5):1026-1033. PubMed ID: 34166722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Maddrey Discriminant Function, Child-Pugh Score and Glasgow Alcoholic Hepatitis Score in predicting 28-day mortality on admission in patients with acute hepatitis.
    Ali S; Hussain S; Hair M; Shah AA
    Ir J Med Sci; 2013 Mar; 182(1):63-8. PubMed ID: 22544466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).
    Sidhu SS; Goyal O; Singla P; Gupta D; Sood A; Chhina RS; Soni RK
    Dig Dis Sci; 2012 Jun; 57(6):1664-71. PubMed ID: 22388710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the management of alcoholic steatohepatitis.
    Stickel F; Seitz HK
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):189-97. PubMed ID: 23799218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial.
    Shasthry SM; Sharma MK; Shasthry V; Pande A; Sarin SK
    Hepatology; 2019 Sep; 70(3):802-811. PubMed ID: 30664267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis and treatment of patients with acute alcoholic hepatitis.
    Papastergiou V; Burroughs AK; Tsochatzis EA
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):471-86. PubMed ID: 24716632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
    Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
    Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Amjad W; Alukal J; Doycheva I; Zhang T; Maheshwari A; Yoo H; Thuluvath PJ
    Dig Dis Sci; 2020 Dec; 65(12):3726-3733. PubMed ID: 32072435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Three prognostic scales; clinical utility and prediction of intrahospital survival in alcoholic hepatitis].
    Altamirano-Gómez JT; Zapata-Irissón L; Augustin-Recio S; Muntaner-Muñoz L; González-Angulo A; Ortiz-Salgado A
    Rev Gastroenterol Mex; 2009; 74(1):18-25. PubMed ID: 19666315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease.
    Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T
    Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of a new prognostic index for alcoholic hepatitis.
    Almeida JR; Araújo RC; Castilho GV; Stahelin L; Pandolfi Ldos R; Silva CQ
    Arq Gastroenterol; 2015; 52(1):22-6. PubMed ID: 26017078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe acute alcoholic hepatitis].
    Nguyen-Khac E; Dejour V; Sarba R; Yzet T; Chatelain D; Marcq I; Chivot C; Papillon CA; Attencourt C; Houchi H
    Presse Med; 2018; 47(7-8 Pt 1):655-666. PubMed ID: 30032921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.